Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Engel

Showing results (251-260 of 376) with videos related to

Pageof 38
Sort By:
JAMA Internal Medicine|July 19, 2016
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical TrialFrank Bloos, Evelyn Trips, Axel Nierhaus, et al.
Breast Cancer Research : BCR|May 1, 2019
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancerNana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2019
The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort EffectSanne W Ten Broeke, Mar Rodríguez-Girondo, Manon Suerink, et al.
International Journal of Cancer|September 3, 2020
Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnosticsHendrik Bläker, Saskia Haupt, Monika Morak, et al.
Critical Care Science|January 24, 2024
Intensive glucose control in critically ill adults: a protocol for a systematic review and individual patient data meta-analysisDerick Adigbli, Li Yang, Naomi Hammond, et al.
The Journal of Pathology|July 21, 2017
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndromeHans Binder, Lydia Hopp, Michal R Schweiger, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 22, 2024
Calculating Future 10-Year Breast Cancer Risks in Risk-Adapted Surveillance: A Method Comparison and Application in Clinical PracticeSilke Zachariae, Anne S Quante, Marion Kiechle, et al.
Journal of the National Cancer Institute|December 29, 2020
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation CarriersJulika Borde, Corinna Ernst, Barbara Wappenschmidt, et al.
Breast Cancer Research : BCR|January 26, 2018
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancerNana Weber-Lassalle, Jan Hauke, Juliane Ramser, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2026
Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancerNatalie Herold, Christoph Engel, Dorothee Speiser, et al.
Pageof 38

Showing results (251-260 of 376) with videos related to

Sort By:
Pageof 38
JAMA Internal Medicine|July 19, 2016
Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical TrialFrank Bloos, Evelyn Trips, Axel Nierhaus, et al.
Breast Cancer Research : BCR|May 1, 2019
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancerNana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 3, 2019
The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort EffectSanne W Ten Broeke, Mar Rodríguez-Girondo, Manon Suerink, et al.
International Journal of Cancer|September 3, 2020
Age-dependent performance of BRAF mutation testing in Lynch syndrome diagnosticsHendrik Bläker, Saskia Haupt, Monika Morak, et al.
Critical Care Science|January 24, 2024
Intensive glucose control in critically ill adults: a protocol for a systematic review and individual patient data meta-analysisDerick Adigbli, Li Yang, Naomi Hammond, et al.
The Journal of Pathology|July 21, 2017
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndromeHans Binder, Lydia Hopp, Michal R Schweiger, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 22, 2024
Calculating Future 10-Year Breast Cancer Risks in Risk-Adapted Surveillance: A Method Comparison and Application in Clinical PracticeSilke Zachariae, Anne S Quante, Marion Kiechle, et al.
Journal of the National Cancer Institute|December 29, 2020
Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation CarriersJulika Borde, Corinna Ernst, Barbara Wappenschmidt, et al.
Breast Cancer Research : BCR|January 26, 2018
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancerNana Weber-Lassalle, Jan Hauke, Juliane Ramser, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2026
Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancerNatalie Herold, Christoph Engel, Dorothee Speiser, et al.
Pageof 38